Philip Morris International Inc. Update on Holding of Medicago Inc.
NEW YORK, December 10, 2010 -- Philip Morris International Inc. (NYSE / Euronext Paris: PM) confirms that its investment in Medicago Inc. ("Medicago"), formerly held by Philip Morris Participations B.V., is now held by Philip Morris Investments B.V., a wholly owned indirect subsidiary of Philip Morris International Inc. ("PMI"). The current holding of Philip Morris Investments B.V. in Medicago remains unchanged and consists of 45,000,000 common shares, representing 32.86% of the issued and outstanding common shares of Medicago when calculated on a non-fully diluted basis. Based on Medicago’s most recent notification of the total number of common shares issued and outstanding, PMI remains its largest shareholder.
PMI may, subject to market conditions and in accordance with applicable securities laws, make additional investments in, or dispositions of, securities of Medicago, including additional purchases of Medicago’s common shares.
Philip Morris International Inc. Profile Philip Morris International Inc. (PMI) is the leading international tobacco company, with seven of the world’s top 15 brands, including Marlboro, the number one cigarette brand worldwide. PMI’s products are sold in approximately 160 countries. In 2009, the company held an estimated 15.4% share of the total international cigarette market outside of the U.S., or 26.0% excluding the People’s Republic of China and the U.S. For more information, see www.pmi.com.
Our Investor Relations mobile application provides simple, comprehensive and up-to-date access to PMI’s disclosed investor relations materials as well as to live and archived audio webcast playback of earnings calls and investor presentations.